INSIGHTS ON LIQUID DOSE MANUFACTURING

• Comparative Evaluation Of NHP And VHP For Isolator Decontamination

  Comparative evaluation reveals how optimizing hydrogen peroxide cycle parameters improves pharmaceutical isolator bio-decontamination efficiency while maintaining Annex 1 sterility compliance.

• Minimizing Particulate Risk

  While visible particles often draw immediate attention, visual inspection alone is insufficient, as subvisible particulate matter can pose equally significant risks to patient safety.

• Simplify Cell Line Development

  A streamlined workflow combining microfluidic dispensing and multimodal imaging enables efficient single-cell isolation, viability assessment, and outgrowth analysis to support cell line development.

• Filling Syringes With Spray-Dried Powders - The How, The Why And The Benefits

  Discover how filling spray-dried powders directly into syringes improves stability, minimizes cold chain reliance, and accelerates administration speeds for critical therapies.

• Economic Advantage Of Robotic Gloveless Pharmaceutical Isolators

  4/28/2025

  Are robotic gloveless isolators the key to smarter, safer, scalable solutions? Discover how they can revolutionize aseptic filling by reducing contamination, minimizing waste, and enhancing manufacturing flexibility.

• Global Regulatory Harmonization: Comparisons In Aseptic Barrier Systems

  4/20/2026

  Compare global aseptic standards from the FDA, EMA, PIC/S, and WHO. Gain insights into how advanced barrier systems harmonize international requirements to ensure sterile product integrity and safety.

• The Fill/Finish Timeline: What Comes After Manufacturing

  6/15/2026

  The post-manufacturing backend of sterile injectable fill-finish operates in a strict sequence—encompassing inspection, testing, QA review, and complex labeling validation—requiring early planning to avoid timeline delays.

• Commercially Proven Sterile Fill/Finish With Capacity And Global Backing

  1/27/2026

  Find comprehensive solution with new sterile fill/finish investments supporting complex molecules through robust tech transfer, commercialization expertise, and integrated cGMP manufacturing solutions.

• The Clear Solution: Navigating Contamination Control For Ophthalmic Injectables

  8/12/2026

  As the intravitreal therapy market grows and applicable regulations evolve, continued compliance demands technological savvy and rigorous contamination control.